{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:04Z","timestamp":1790741944389,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:00:00Z","timestamp":1204588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/ncprheum0760","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T08:09:43Z","timestamp":1204618183000},"page":"201-209","source":"Crossref","is-referenced-by-count":86,"title":["Mechanisms of Disease: autoantigens as clues to the pathogenesis of myositis"],"prefix":"10.1038","volume":"4","author":[{"given":"Tomeka L","family":"Suber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,4]]},"reference":[{"key":"BFncprheum0760_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487\u20131498","journal-title":"N Engl J Med"},{"key":"BFncprheum0760_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA et al. (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70: 360\u2013374","journal-title":"Medicine (Baltimore)"},{"key":"BFncprheum0760_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","volume":"12","author":"IN Targoff","year":"2000","unstructured":"Targoff IN (2000) Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 12: 475\u2013481","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0760_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.cdd.4400460","volume":"6","author":"A Rosen","year":"1999","unstructured":"Rosen A and Casciola-Rosen L (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 6: 6\u201312","journal-title":"Cell Death Differ"},{"key":"BFncprheum0760_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L et al. (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201: 591\u2013601","journal-title":"J Exp Med"},{"key":"BFncprheum0760_CR6","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1101\/gad.13.15.1924","volume":"13","author":"Y Zhang","year":"1999","unstructured":"Zhang Y et al. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924\u20131935","journal-title":"Genes Dev"},{"key":"BFncprheum0760_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.immuni.2004.05.005","volume":"20","author":"CJ Williams","year":"2004","unstructured":"Williams CJ et al. (2004) The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. Immunity 20: 719\u2013733","journal-title":"Immunity"},{"key":"BFncprheum0760_CR8","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1242\/dev.001750","volume":"134","author":"M Kashiwagi","year":"2007","unstructured":"Kashiwagi M et al. (2007) The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development 134: 1571\u20131582","journal-title":"Development"},{"key":"BFncprheum0760_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20020186","volume":"196","author":"OM Howard","year":"2002","unstructured":"Howard OM et al. (2002) Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 196: 781\u2013791","journal-title":"J Exp Med"},{"key":"BFncprheum0760_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6: 823\u2013835","journal-title":"Nat Rev Immunol"},{"key":"BFncprheum0760_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR et al. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417\u2013428","journal-title":"Immunity"},{"key":"BFncprheum0760_CR12","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/art.20254","volume":"50","author":"T Lovgren","year":"2004","unstructured":"Lovgren T et al. (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50: 1861\u20131872","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0760_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI23025","volume":"115","author":"TK Means","year":"2005","unstructured":"Means TK et al. (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115: 407\u2013417","journal-title":"J Clin Invest"},{"key":"BFncprheum0760_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1471-4906(01)01955-X","volume":"22","author":"L Ronnblom","year":"2001","unstructured":"Ronnblom L and Alm GV (2001) An etiopathogenic role for the type I IFN system in SLE. Trends Immunol 22: 427\u2013431","journal-title":"Trends Immunol"},{"key":"BFncprheum0760_CR15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1084\/jem.20051696","volume":"202","author":"J Vollmer","year":"2005","unstructured":"Vollmer J et al. (2005) Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 202: 1575\u20131585","journal-title":"J Exp Med"},{"key":"BFncprheum0760_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","volume":"25","author":"J Banchereau","year":"2006","unstructured":"Banchereau J and Pascual V (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383\u2013392","journal-title":"Immunity"},{"key":"BFncprheum0760_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau CM et al. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J Exp Med 202: 1171\u20131177","journal-title":"J Exp Med"},{"key":"BFncprheum0760_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter EA et al. (2002) Chromatin\u2013IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603\u2013607","journal-title":"Nature"},{"key":"BFncprheum0760_CR19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA et al. (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57: 664\u2013678","journal-title":"Ann Neurol"},{"key":"BFncprheum0760_CR20","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.4049\/jimmunol.154.7.3516","volume":"154","author":"LK Bockenstedt","year":"1995","unstructured":"Bockenstedt LK et al. (1995) Self-peptides in the initiation of lupus autoimmunity. J Immunol 154: 3516\u20133524","journal-title":"J Immunol"},{"key":"BFncprheum0760_CR21","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels N et al. (1996) Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 97: 2905\u20132910","journal-title":"J Clin Invest"},{"key":"BFncprheum0760_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.190.6.815","volume":"190","author":"L Casciola-Rosen","year":"1999","unstructured":"Casciola-Rosen L et al. (1999) Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 190: 815\u2013826","journal-title":"J Exp Med"},{"key":"BFncprheum0760_CR23","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.7326\/0003-4819-50-5-1174","volume":"50","author":"RC Williams Jr","year":"1959","unstructured":"Williams RC Jr (1959) Dermatomyositis and malignancy: a review of the literature. Ann Intern Med 50: 1174\u20131181","journal-title":"Ann Intern Med"},{"key":"BFncprheum0760_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.7326\/0003-4819-84-1-68","volume":"84","author":"BE Barnes","year":"1976","unstructured":"Barnes BE and Mawr B (1976) Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 84: 68\u201376","journal-title":"Ann Intern Med"},{"key":"BFncprheum0760_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B et al. (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326: 363\u2013367","journal-title":"N Engl J Med"},{"key":"BFncprheum0760_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL et al. (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357: 96\u2013100","journal-title":"Lancet"},{"key":"BFncprheum0760_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","volume":"18","author":"SM Levine","year":"2006","unstructured":"Levine SM (2006) Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 18: 620\u2013624","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0760_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R et al. (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134: 1087\u20131095","journal-title":"Ann Intern Med"},{"key":"BFncprheum0760_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","volume":"14","author":"Z Amoura","year":"2005","unstructured":"Amoura Z et al. (2005) Tumor antigen markers for the detection of solid cancers in inflammatory myopathies. Cancer Epidemiol Biomarkers Prev 14: 1279\u20131282","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFncprheum0760_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","volume":"9","author":"JJ Nordlund","year":"1983","unstructured":"Nordlund JJ et al. (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9: 689\u2013696","journal-title":"J Am Acad Dermatol"},{"key":"BFncprheum0760_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","volume":"33","author":"RB Darnell","year":"2006","unstructured":"Darnell RB and Posner JB (2006) Paraneoplastic syndromes affecting the nervous system. Semin Oncol 33: 270\u2013298","journal-title":"Semin Oncol"},{"key":"BFncprheum0760_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa053007","volume":"354","author":"H Gogas","year":"2006","unstructured":"Gogas H et al. (2006) Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354: 709\u2013718","journal-title":"N Engl J Med"},{"key":"BFncprheum0760_CR33","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1172\/JCI118218","volume":"96","author":"Q Ge","year":"1995","unstructured":"Ge Q et al. (1995) Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 96: 1730\u20131737","journal-title":"J Clin Invest"},{"key":"BFncprheum0760_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/12664","volume":"23","author":"PA Wade","year":"1999","unstructured":"Wade PA et al. (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23: 62\u201366","journal-title":"Nat Genet"},{"key":"BFncprheum0760_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/ard.2005.040717","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ et al. (2006) Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis 65: 242\u2013245","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0760_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"T Miller","year":"2002","unstructured":"Miller T et al. (2002) Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73: 420\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncprheum0760_CR37","doi-asserted-by":"publisher","first-page":"35362","DOI":"10.1074\/jbc.273.52.35362","volume":"273","author":"PJ Utz","year":"1998","unstructured":"Utz PJ et al. (1998) The 72-kDa component of signal recognition particle is cleaved during apoptosis. J Biol Chem 273: 35362\u201335370","journal-title":"J Biol Chem"},{"key":"BFncprheum0760_CR38","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.1780351014","volume":"35","author":"CV Oddis","year":"1992","unstructured":"Oddis CV et al. (1992) Serum autoantibody to the nucleolar antigen PM\/Scl. Clinical and immunogenetic associations. Arthritis Rheum 35: 1211\u20131217","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0760_CR39","doi-asserted-by":"publisher","first-page":"30698","DOI":"10.1074\/jbc.M302488200","volume":"278","author":"R Raijmakers","year":"2003","unstructured":"Raijmakers R et al. (2003) The association of the human PM\/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus. J Biol Chem 278: 30698\u201330704","journal-title":"J Biol Chem"},{"key":"BFncprheum0760_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/art.20056","volume":"50","author":"R Raijmakers","year":"2004","unstructured":"Raijmakers R et al. (2004) PM\/Scl-75 is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome. Arthritis Rheum 50: 565\u2013569","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0760_CR41","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar2119","volume":"9","author":"G Schilders","year":"2007","unstructured":"Schilders G et al. (2007) Caspase-mediated cleavage of the exosome subunit PM\/Scl-75 during apoptosis. Arthritis Res Ther 9: R12","journal-title":"Arthritis Res Ther"},{"key":"BFncprheum0760_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1529-0131(200102)44:2<389::AID-ANR58>3.0.CO;2-R","volume":"44","author":"LA Casciola-Rosen","year":"2001","unstructured":"Casciola-Rosen LA et al. (2001) The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum 44: 389\u2013396","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0760_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ijc.21118","volume":"116","author":"T Okada","year":"2005","unstructured":"Okada T et al. (2005) Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis. Int J Cancer 116: 925\u2013933","journal-title":"Int J Cancer"},{"key":"BFncprheum0760_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","volume":"109","author":"SA Rutjes","year":"1997","unstructured":"Rutjes SA et al. (1997) Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109: 32\u201340","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0760_CR45","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","volume":"176","author":"A Espinosa","year":"2006","unstructured":"Espinosa A et al. (2006) The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol 176: 6277\u20136285","journal-title":"J Immunol"},{"key":"BFncprheum0760_CR46","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1084\/jem.182.6.1625","volume":"182","author":"LA Casciola-Rosen","year":"1995","unstructured":"Casciola-Rosen LA et al. (1995) DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 182: 1625\u20131634","journal-title":"J Exp Med"},{"key":"BFncprheum0760_CR47","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.onc.1208332","volume":"24","author":"SJ Collis","year":"2005","unstructured":"Collis SJ et al. (2005) The life and death of DNA-PK. Oncogene 24: 949\u2013961","journal-title":"Oncogene"},{"key":"BFncprheum0760_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1172\/JCI110295","volume":"68","author":"T Mimori","year":"1981","unstructured":"Mimori T et al. (1981) Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis\u2013scleroderma overlap. J Clin Invest 68: 611\u2013620","journal-title":"J Clin Invest"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0760","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncprheum0760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:11:01Z","timestamp":1684429861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BFncprheum0760"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0760","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1255991.723093","asserted-by":"object"}]},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,4]]}}}